Llorens JV, Soriano S, Calap-Quintana P, Gonzalez-Cabo P and Moltó MD (2019). Front. Neurosci. 13:75. doi: 10.3389/fnins.2019.00075
we review the contribution of the cellular and animal models of FRDA and relevance of the studies using FRDA patient samples to gain knowledge about these issues. Mechanisms of mitochondrial iron overload are discussed considering the potential roles of frataxin in the major mitochondrial metabolic pathways that use iron. We also analyzed the effect of iron toxicity on neuronal degeneration in FRDA by reactive oxygen species (ROS)-dependent and ROS-independent mechanisms. Finally, therapeutic strategies based on the control of iron toxicity are considered.
Thursday, February 21, 2019
Subscribe to:
Posts (Atom)
